| HOME >> MEDICINE >> TECHNOLOGY |
MINNEAPOLIS, Nov. 6, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in two upcoming investor conferences in November – the Stephens Fall Investment Conference and the Lazard 9th Annual Healthcare Conference. Detailed information is provided below:What:
Stephens Fall Investment ConferenceWhere:
New York Palace Hotel, New York, NYDate:
Tuesday, November 13, 2012Time:
4:00 pm ET
What:
Lazard 9th Annual Healthcare ConferenceWhere:
Pierre Hotel, New York, NYDate:
Wednesday, November 14, 2012Time:
11:00 am ETDavid Kaysen, President and CEO, and Medi Jiwani, Chief Financial Officer, will discuss recent financial results and current corporate developments at both conferences.
Uroplasty will offer a live audio webcast of both events on the Company's website, www.uroplasty.com, under Investor Information. An archived replay of the presentation will be available for 30 days, also at www.uroplasty.com.
About Uroplasty, Inc.Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom is a global medical company committed to offering transformative treatment options to specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-bas
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2012 PR Newswire. All rights reserved |